About TrialSiteNews

159 W Broadway, Suite 200 Salt Lake City, UT 84101

TrialSiteNews was launched to drive more interest and awareness in clinical research, as well as to develop trust and facilitate engagement of researchers and the public. TrialSite started toward the end of 2018, financed solely by the founder, to create a new disruptive force in the world of biomedical research.

TrialSite emphasizes the trial site organization and its staff, whether a hospital, health system, community clinic, or commercial research center, and the breakthroughs, challenges, best practices, and mishaps, all in a bid to provide more transparency for the broader population as to the nuts and bolts of clinical trials.

Have something important to share with our editorial team? Email us… If you need support or have login issues – please use help@trialsitenews.com or the chat (bottom right)

Mission & Values

TrialSite’s mission is to drive awareness, introduce transparency, and facilitate engagement among people all over the world, from pharmaceutical professionals and academic researchers to regulators and healthcare professionals along with a wide array of the consuming public.

We value transparency, objectivity, and the scientific method in pursuit of the truth wherever it may lead us.


Daniel O’Connor

Founder / CEO

Mark Hadfield

Head of Digital

159 W Broadway, Suite 200
Salt Lake City, UT 84101
© 2024 - Trial Site News